0000905718-16-001092.txt : 20160121 0000905718-16-001092.hdr.sgml : 20160121 20160121172424 ACCESSION NUMBER: 0000905718-16-001092 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160121 DATE AS OF CHANGE: 20160121 EFFECTIVENESS DATE: 20160121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Variant Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001613083 IRS NUMBER: 465188564 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-255702 FILM NUMBER: 161354228 BUSINESS ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 BUSINESS PHONE: 954-931-2075 MAIL ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 D 1 primary_doc.xml X0707 D LIVE 0001613083 Variant Pharmaceuticals, Inc. 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 954-931-2075 FLORIDA None None Corporation true 2014 Stephen C Glover 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Executive Officer Director Shawn M Titcomb 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Nico Pronk 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Aaron Greenblatt 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Pharmaceuticals No Revenues 06b false true false true false 0 Craft Capital Management LLC 171350 None None 377 OAK STREET STE. 402 GARDEN CITY NY NEW YORK 11530 CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA MD MARYLAND MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NV NEVADA NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA SC SOUTH CAROLINA SD SOUTH DAKOTA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN WY WYOMING false MIP Bahamas LTD None None None SUITE 8 SOUTH BUCKER SQUARE SANDYPORT MARINA VILLAGE C5 BAHAMAS Bahamas true 25000000 0 25000000 false 0 2000000 true 80000 true Assumes maximum offering sold by Craft Capital Management LLC. Excludes warrants to purchase up to 166,666 shares at an exercise price of $3.00 per share as set forth in the offering documents. 0 true Some of the proceeds will be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false Variant Pharmaceuticals, Inc. /s/ Stephen C. Glover Stephen C. Glover CEO 2016-01-21